Pediatrix Medical Group, Inc. $MD Shares Bought by CSM Advisors LLC

CSM Advisors LLC raised its holdings in Pediatrix Medical Group, Inc. (NYSE:MD) by 54.7% during the 3rd quarter, Holdings Channel.com reports. The firm owned 313,675 shares of the company’s stock after acquiring an additional 110,877 shares during the period. CSM Advisors LLC’s holdings in Pediatrix Medical Group were worth $5,253,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Royal Bank of Canada lifted its holdings in shares of Pediatrix Medical Group by 23.8% in the 1st quarter. Royal Bank of Canada now owns 22,097 shares of the company’s stock valued at $320,000 after buying an additional 4,247 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Pediatrix Medical Group by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 51,253 shares of the company’s stock worth $743,000 after acquiring an additional 2,251 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Pediatrix Medical Group by 4.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 268,506 shares of the company’s stock worth $3,891,000 after acquiring an additional 12,171 shares during the period. Connor Clark & Lunn Investment Management Ltd. raised its position in Pediatrix Medical Group by 284.6% during the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 175,987 shares of the company’s stock valued at $2,525,000 after acquiring an additional 130,226 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in Pediatrix Medical Group by 6.9% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 21,620 shares of the company’s stock valued at $310,000 after acquiring an additional 1,393 shares during the period. 97.71% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. Deutsche Bank Aktiengesellschaft set a $19.00 price objective on Pediatrix Medical Group in a research report on Friday, February 20th. Truist Financial dropped their price objective on Pediatrix Medical Group from $24.00 to $21.00 and set a “hold” rating on the stock in a report on Thursday, February 19th. Weiss Ratings restated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Monday, December 29th. Zacks Research downgraded Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 23rd. Finally, Jefferies Financial Group upgraded Pediatrix Medical Group to a “strong-buy” rating in a research report on Thursday. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $19.80.

Pediatrix Medical Group Price Performance

Shares of Pediatrix Medical Group stock opened at $19.58 on Monday. The stock has a market capitalization of $1.63 billion, a P/E ratio of 10.09 and a beta of 0.79. The business has a 50 day simple moving average of $20.93 and a two-hundred day simple moving average of $20.05. Pediatrix Medical Group, Inc. has a 12 month low of $11.84 and a 12 month high of $24.99. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.66.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Thursday, February 19th. The company reported $0.50 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.03). Pediatrix Medical Group had a return on equity of 19.59% and a net margin of 8.64%.The firm had revenue of $493.77 million during the quarter, compared to analyst estimates of $486.23 million. During the same period in the prior year, the firm earned $0.51 earnings per share. The business’s revenue was down 1.7% on a year-over-year basis. As a group, analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.